| 1. Correlation among serum levels of resistin,ox-LDL,hsCRP and severity of acute ischemic cerebrovas- |
Page:45—48 |
| 2. Relationship between acute myocardial infarction and original sites of premature ventricular contrac-tion |
Page:41—44 |
| 3. Relationship among severity of cerebral infarction, arteriosclerosis and serum CysC level in young and ;middle-aged patients with atherosclerotic cerebral infarction |
Page:37—40 |
| 4. Relationship between blood pressure variability and left ventricular diastolic function in patients with ;essential hypertension |
Page:33—36 |
| 5. Correlation between carotid lesion severity detected by ultrasound and PAPP-A expression in ACS pa-tients |
Page:20—23 |
| 6. Influence of exercise rehabilitation combined diet guidance on patients after heart valve replacement |
Page:16—20 |
| 7. Relationship among serum homocysteine level, paraoxonase 1 activity and carotid atherosclerosis |
Page:8—12 |
| 8. Influence of early rehabilitation therapy on prognosis and quality of life in patients with acute myocar-dial infarction |
Page:5—7 |
| 9. Correlation between medication adherence and quality of life in aged patients with hypertension from ;communi ties |
Page:1—4 |
| 10. Therapeutic effect of cardiopulmonary resuscitation and nursing intervention on patients with massive ;myocardial infarction complicated cardiac arrest |
Page:116—119 |
| 11. Therapeutic effect of nursing exercise rehabilitation on home patients with chronic heart failure |
Page:112—115 |
| 12. Application of self-efficacy scale in postoperative nursing of patients undergoing coronary artery bypass ;grafting |
Page:108—111 |
| 13. Therapeutic effect of Tanshinone IIA-sulfonic sodium on CHD patients and its influence on hemorheolo-gy,cytokines and blood lipid levels |
Page:104—107 |
| 14. Diagnostic value of dynamic electrocardiogram combined esophageal electrophysiological examination ;for sick sinus syndrome |
Page:101—103 |
| 15. Clinical characteristics of reperfusion arrhythmia during direct percutaneous coronary intervention in ;AMI patients and its influence on prognosis |
Page:94—97 |
| 16. Therapeutic effect of Fasudil combined Salmeterol Xinafoate and fluticasone propionate powder for in-halation on patients with COPD complicated PAH |
Page:90—94 |
| 17. Influence of probucol combined atorvastatin on blood viscosity,TCD indexes and carotid plaque stabili-ty in patients with large artery-derived cerebral infarction |
Page:86—90 |
| 18. Therapeutic effect of atorvastatin combined clopidogrel on patients with angina pectoris and their prog-nosis |
Page:82—85 |
| 19. Heart rate variability change after circumferential pulmonary vein ablation in patients with paroxysmal ;atrial fibrillation and its relationship with recurrence |
Page:78—82 |
| 20. Therapeutic effect of ticagrelor on acute ST elevation myocardial infarction and its influence on short-term prognosis |
Page:74—77 |
| 21. Cardiac repair effect of AKT transfected amniotic fluid mesenchymal stem cells on ischemic reperfusion ;injured myocardium in rabbits |
Page:68—73 |
| 22. Influence of hyperglycemia on hospitalization and follow-up prognosis in emergency PCI patients |
Page:63—67 |
| 23. Correlation among heart structure, cardiac function and premature ventricular systole of different ;loads |
Page:55—59 |
| 24. Relationship between slow coronary flow and vascular endothelial function |
Page:52—55 |
| 25. Change of serum sST2 and copeptin levels in patients with chronic heart failure and their correlation |
Page:49—51 |
| 26. Riskfactor analysis of slow coronary flow phenomenon in male patients |
Page:30—33 |
| 27. Influence of waling training on pulmonary function and blood glucose in aged patients with type 2 dia-betes mellitus |
Page:24—27 |
| 28. Risk factors for no-reflow after emergency coronary intervention in aged patients with acute ST eleva-tion myocardial infarction |
Page:12—15 |
| 29. Influence of atorvastatin on levels of hsCRP, IL-6 and TNF-α in patients with acute coronary syndrome |
Page:222—224 |
| 30. Research progress of atrial fibrillation treatment |
Page:219—221 |
| 31. Research progress of Corin in cardiovascular field |
Page:217—219 |
| 32. Effect of comprehensive nursing on patients with arrhythmia after acute myocardial infarction |
Page:214—216 |
| 33. Influence of nursing health education on morning blood pressure surge fluctuations in aged people with hypertension |
Page:210—213 |
| 34. Comparative analysis and application of cardiac noninvasive examination in the diagnosis of coronary heart disease |
Page:193—196 |
| 35. Comparison of therapeutic effects of clopidogrel and loading dose ticagrelor on aged patients with ST elevation myocardial infarction |
Page:189—192 |
| 36. Correlation among plasma fibrinogen, serum uric acid level and premature coronary heart disease |
Page:154—158 |
| 37. Correlation between heart rate variability and arteriosclerosis in patients with essential hypertension |
Page:149—154 |
| 38. Improving effect of tertiary rehabilitation training on upper limb motor function after cerebral hemorrhage |
Page:146—149 |
| 39. Prognosis of patients with coronary heart disease and normal myocardial perfusion imaging |
Page:138—141 |
| 40. Correlation between serum uric acid level and heart failure severity in patients with chronic pulmonary heart disease |
Page:135—138 |
| 41. Application value of pulse wave velocity in physical examination in Shenyang district and its risk factors analysis |
Page:132—135 |
| 42. Influence of glycosylated hemoglobin on major adverse cardiovascular events in patients with diabetes mellitus complicated coronary heart disease after PCI |
Page:129—131 |
| 43. Value of exercise stress test guiding aerobic exercise rehabilitation in patients with myocardial infarction |
Page:125—128 |
| 44. New research progress of neuregulin-1 |
Page:228—230 |
| 45. Research progress in relationship between high sensitive C-reactive protein and coronary heart disease |
Page:225—227 |
| 46. Evaluation effect of three-dimensional speckle tracking imaging on left ventricular systolic function in patients with acute anterior myocardial infarction |
Page:206—209 |
| 47. Early diagnostic and resent prognostic assessment value of cTnI and IMA for acute coronary syndrome |
Page:202—205 |
| 48. Therapeutic effect of alprostadil on improving myocardial microcirculatory disturbance and hemorheology in patients with coronary heart disease |
Page:199—202 |
| 49. Influencing factors for aspirin resistance in women with ischemic stroke |
Page:196—198 |
| 50. Risk factors of percutaneous coronary intervention-induced vagal reflex and clinical emergency treatment |
Page:185—189 |
| 51. Mechanism of fasudil combined Seretide in treating COPD complicated pulmonary artery hypertension |
Page:182—185 |
| 52. Influence of enalapril folic acid tablet on blood pressure and blood glucose levels in patients with H-type hypertension complicated diabetes mellitus |
Page:177—181 |
| 53. Current prevalence condition of hypertension in professional drivers and analysis of related influencing factors |
Page:174—176 |
| 54. Correlation among serum lipoprotein a, uric acid levels and cardiac function in patients with acute myocardial infarction complicated diabetes mellitus |
Page:170—173 |
| 55. Correlation between plasma oxidized low density lipoprotein and vascular endothelial injury degree in patients with coronary heart disease |
Page:167—170 |
| 56. Diagnostic and predictive value of hsCRP and CysC levels for acute coronary syndrome in aged patients |
Page:165—167 |
| 57. Relationship among smoking, levels of homocysteine, C reactive protein and coronary heart disease onset in young people |
Page:162—164 |
| 58. Relationship among somatostatin, neuron-specific enolase and early vascular dementia |
Page:159—162 |
| 59. Correlation among concentrations of high sensitive C reactive protein, uric acid, brain natriuretic peptide and coronary heart disease |
Page:142—145 |
| 60. Correlation between new arterial stiffness indexes and early atherosclerosis in middle-aged population |
Page:121—124 |
| 61. Clinical significance of sinus heart rate turbulence in aged patients with stable angina pectoris |
Page:98—100,101 |
| 62. Trend and epidemiological analysis of congenital heart disease |
Page:60—62,63 |
| 63. Influence of rehabilitation exercise on daily living capacity in aged patients with chronic heart failure |
Page:27—29,30 |
| 64. Manifestation of cardiac troponin in non-coronary heart diseases |
Page:457—460 |
| 65. Therapeutic effect of behavioral nursing on patients with atherosclerotic stenosis after percutaneous coronary intervention |
Page:453—456 |
| 66. ECG diagnostic analysis of pacemaker-induced rapid arrhythmias |
Page:449—452 |
| 67. Therapeutic effect of atorvastatin on asymptomatic heart failure after myocardial infarction and its influence on prognosis |
Page:445—448 |
| 68. Therapeutic effect of pharyngeal treatment machine combined resuscitating acupuncture on dysphagia after stroke |
Page:437—441 |
| 69. Comparison of therapeutic effects on type 2 diabetes mellitus between GLP-1 receptor stimulant and DPP-4 inhibitor |
Page:434—437 |
| 70. Study for improving effect on ventricular structure and clinic effect of fasudil in patients with heart failure |
Page:431—434 |
| 71. Therapeutic effect of neuromuscular electrical stimulation combined swallowing training on dysphagia after stroke |
Page:428—431 |
| 72. Influence of trimetazidine on cardiac function, plasma levels of BNP and Hcy in patients with congestive heart failure |
Page:424—427 |
| 73. Therapeutic effects of sodium nitroprusside combined verapamil for no-reflow during percutaneous coronary intervention |
Page:416—419 |
| 74. Therapeutic effect of statins on patients with diabetes mellitus complicated atherosclerotic cardiovascular diseases |
Page:413—416 |
| 75. Influence of tirofiban on endothelial cell function in patients with myocardial infarction undergoing emergency PCI |
Page:410—413 |
| 76. Influence of ticagrelor combined tirofiban on STEMI patients after PCI and their short-term prognosis |
Page:405—409 |
| 77. Influence of atorvastatin combined trimetazidine on levels of blood lipids, inflammatory factors and cardiac function in patients with coronary heart disease |
Page:398—401 |
| 78. Therapeutic effect of recombinant human brain natriuretic peptide on aged patients with acute decompensated heart failure |
Page:395—398 |
| 79. Correlation among serum UA, Hcy levels and coronary disease severity in aged patients with coronary heart disease |
Page:391—394 |
| 80. Correlation among blood lipids and main inflammatory factors levels in patients with coronary heart disease complicated hyperlipidemia |
Page:388—390 |
| 81. Correlation among plasma BNP, D-dimer levels and patient′s status in patients with acute pulmonary embolism |
Page:384—388 |
| 82. Correlation among serum vitamin D,folic acid and homocysteine levels in patients with type 2 diabetes mellitus |
Page:378—380 |
| 83. Clinical characteristics and risk factors of young patients with coronary heart disease complicated metabolic syndrome |
Page:375—378 |
| 84. Clinical predictive value of serum hsCRP for risk of acute cerebral infarction |
Page:372—375 |
| 85. Therapeutic effect of individualized cognitive training on improving cognitive function in aged CHD patients after PCI |
Page:368—372 |
| 86. Relationship among plasma BNP level and cardiac function and prognosis in patients with acute heart failure |
Page:364—367 |
| 87. Change of lymphocyte KCa3.1 and CaN-NFAT signaling pathway in Kazak hypertensive patients from Xinjiang |
Page:355—359 |
| 88. Traditional Chinese medicine exercise therapy in cardiovascular rehabilitation field |
Page:460—462 |
| 89. Therapeutic effect of rosuvastatin combined clopidogrel bisulfate on patients with coronary heart disease |
Page:441—444 |
| 90. Therapeutic effect of atorvastatin on inflammatory factor levels and vascular endothelial function in patients with coronary heart disease |
Page:420—424 |
| 91. Preventive effect of alprostadil on contrast-induced nephropathy in high risk patients after PCI |
Page:402—405 |
| 92. Influence of relaxation training combined mindfulness therapy on PCI perioperative psychological stress and quality of life in aged CHD patients |
Page:381—384 |
| 93. Experimental study on regulating effect of protosappanin A on dendritic cell maturation and functional state |
Page:359—364 |
| 94. Application of cryoablation in treatment of paroxysmal supraventricular tachycardia |
Page:349—351 |
| 95. Diagnostic and therapeutic progress of coronary heart disease |
Page:346—349 |
| 96. Therapeutic effect of carvedilol combined valsartan on chronic heart failure |
Page:310—313 |
| 97. Therapeutic effect of aortic endovascular stent-graft exclusion combined PCI on patients with descending thoracic aortic dissection complicated CHD |
Page:299—303 |
| 98. Influence of evidence based nursing strategies on negative emotion and daily behavior in aged patients with coronary heart disease |
Page:338—342 |
| 99. Assessment value of thromboelastogram for thrombus risk in patients with coronary heart disease complicated hypertension |
Page:334—337 |
| 100. Auxiliary diagnostic value of fragmented QRS complex for myocardial infarction |
Page:331—334 |
| 101. Therapeutic effects of calcium channel blocker combined statins on aged patients with hypertension |
Page:306—310 |
| 102. Therapeutic effect of levosimendan combined dobutamine on refractory heart failure |
Page:320—323 |
| 103. Transesophageal echocardiography inspection comparison between patients with patent foramen ovale complicated paradoxical embolism and asymptomatic patent foramen ovale |
Page:318—320 |
| 104. Influence of urokinase on expression of soluble CD40 ligand in patients with acute coronary syndrome |
Page:314—317 |
| 105. Therapeutic effect of tolvaptan on chronic heart failure |
Page:303—305 |
| 106. Therapeutic effects of angiotensin receptor blocker irbesartan on hypertension and its compliance |
Page:292—295 |
| 107. Influence of MAC combined enalapril on BNP, RDW levels in patients with chronic heart failure |
Page:288—291 |
| 108. Influence of bisoprolol on neuroendocrine factor levels in patients with chronic heart failure and its therapeutic effects |
Page:285—288 |
| 109. Therapeutic effect of alprostadil on renal function in patients with acute myocardial infarction complicated diabetic nephropathy undergoing PCI |
Page:281—284 |
| 110. Effects of large dose gamma globulin on cardiac function and immune regulation in patients with dilated cardiomyopathy and heart failure |
Page:277—281 |
| 111. Diagnostic value of brain natriuretic peptide and urine microalbuminuria for patients with heart failure |
Page:269—273 |
| 112. Correlation among clinic blood pressure, ambulatory blood pressure and cardiovascular diseases in diabetic populations |
Page:265—269 |
| 113. Influencing factors for sudden cardiac death in inpatients |
Page:261—264 |
| 114. Correlation between QRS complex duration and left ventricular ejection fraction in patients with complete left bundle branch block |
Page:259—261 |
| 115. Clinical study of blood pressure variability in aged patients with H type hypertension |
Page:254—258 |
| 116. Influence of ginsenoside Rg1 on myocardial angiogenesis in rats after myocardial infarction |
Page:245—250 |
| 117. Assessment value of heart rate variability for cardiac autonomic nervous function in patients with acute stroke |
Page:242—245 |
| 118. Comparison of clinical characteristics and severity of coronary lesions between young and aged patients with acute myocardial infarction |
Page:238—241 |
| 119. Therapeutic effect of modified constraint-induced movement therapy in rehabilitation of patients with stroke hemiplegia |
Page:234—237 |
| 120. Current condition and research progress of self-management in patients after percutaneous coronary intervention |
Page:351—353 |
| 121. Research progress of the relationship between miRNA and dilated cardiomyopathy |
Page:343—345 |
| 122. Consistency of TEE technique and PAC method in monitoring cardiac volume load and cardiac hemodynamic changes |
Page:328—331 |
| 123. Risk factors complicated cardiovascular and cerebrovascular diseases in patients with refractory hypertension |
Page:324—327 |
| 124. Therapeutic effect of valsartan and enalapril on QT interval dispersion and premature ventricular contraction in patients with hypertension |
Page:295—299 |
| 125. Recent prognosis of acute STEMI patients treated by primary PCI and related factor analysis |
Page:273—276 |
| 126. Observational study of RDW-CV, MMP-2, MMP-9 and TIMP-1 in patients with essential hypertension of different risk stratification |
Page:250—254 |
| 127. Influence of rehabilitative exercise on left ventricular hypertrophy, diastolic function and blood pressure in patients with hypertension |
Page:231—233 |
| 128. Evaluative value of ultrasound contrast for carotid atherosclerotic plaque angiogenesis |
Page:497—499 |
| 129. Exploration of the pathogenesis of hypertension caused by obstructive sleep apnea hypopnea syndrome |
Page:478—482 |
| 130. Plasma level and activity of endotoxin in patients with ischemic stroke |
Page:475—477 |
| 131. Research progress of high intensity interval aerobic training for patients with chronic heart failure |
Page:578—580 |
| 132. New progress of risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy |
Page:574—577 |
| 133. Influence of PDCA nursing on mental state and quality of life in patients with myocardial infarction |
Page:563—566 |
| 134. Role of patient-centered psychological nursing for improving sleep quality of CHD patients |
Page:558—563 |
| 135. Influence of prehospital emergency care connected green channel on rescue effect in patients with acute myocardial infarction |
Page:551—554 |
| 136. Study of high-quality nursing in patients with acute myocardial infarction after percutaneous coronary intervention |
Page:547—550 |
| 137. Influence of secondary turntable abdomen insulin injection positioning ruler on blood glucose and com-plications in patients with diabetes mellitus |
Page:538—541 |
| 138. Influence of benazepril combined trimetazidine on blood FSTL1,PAF and vascular endothelial function in CHD + HF patients |
Page:533—538 |
| 139. Influence of furosemide combined Xinmailong injection on LVEF and blood lactate in patients with chronic heart failure |
Page:529—533 |
| 140. Influence of telmisartan combined amiodarone on blood pressure,left atrial and AF recurrence in pa-tients with hypertension complicated AF |
Page:526—529 |
| 141. Influence of intracoronary tirofiban application on coronary blood flow,endothelial function and in-flammatory factors in AMI patients |
Page:522—526 |
| 142. Anti-platelet/anti-coagulation and their prognosis in advanced aged patients with ACS complicated atri-al fibrillation after PCI |
Page:515—518 |
| 143. High-quality of emergency clinical pathway and therapeutic effect evaluation for PCI in AMI patients |
Page:511—515 |
| 144. Changes of blood adiponectin and heme oxygenase 1 levels after PCI |
Page:507—511 |
| 145. Influence of hydrochlorothiazide combined valsartan on therapeutic effects,cardiac function and levels of serum RBP4,Vaspin in hypertension patients |
Page:503—507 |
| 146. Clinical characteristics of congenital coronary artery fistulas and its coronary angiographic results anal-ysis |
Page:500—502 |
| 147. Role of CYP2C19 gene polymorphism in guidance of anti-platelet therapy after PCI |
Page:493—496 |
| 148. Influence of tanshinone injection combined diltiazem on vascular endothelial function in patients with hypertension |
Page:490—492 |
| 149. Analysis of risk factors for high risk ventricular arrhythmias after emergency PCI |
Page:486—489 |
| 150. Improving effect of cognitive restructuring intervention on mental state and therapeutic compliance in CHD patients |
Page:482—485 |
| 151. Correlation among serum levels of 25 (OH)D,HbA1c,Hcy and intracranial arterial stenosis severity in patients with diabetes mellitus |
Page:470—474 |
| 152. Analysis of risk factors and the prognostic risk factors in aged patients with coronary heart disease |
Page:467—470 |
| 153. Relationship among serum A-FABP,chemokine CXCL12 and onset,severity of AIS in aged AIS pa-tients |
Page:463—466 |
| 154. Progress in the treatment of pulmonary embolism |
Page:570—574 |
| 155. Research progress for pathological mechanism and typing of coronary microcirculation dysfunction |
Page:567—570 |
| 156. Diagnostic value of exercise ECG and dynamic ECG for organic heart disease ventricular premature beat |
Page:542—546 |
| 157. Influence of preoperative intensive atorvastatin therapy on no-reflow and cardiac function after selective PCI |
Page:518—521 |
| 158. Therapeutic effect of spironolactone combined benazepril on patients with acute anterior myocardial in-farction |
Page:648—651 |
| 159. Therapeutic effect of trimetazidine on patients with angina pectoris after PCI and its influence on endo-thelial function and exercise tolerance |
Page:635—639 |
| 160. Research progress of gene therapy for arrhythmias |
Page:670—673 |
| 161. Influence of PCI and thrombolytic therapy on therapeutic effect and reperfusion of AMI patients |
Page:644—647 |
| 162. Value of DSA in diagnosing ischemic cerebrovascular disease and evaluating therapeutic effect after in-tervention |
Page:640—644 |
| 163. Therapeutic effect of atorvastatin combined aspirin on patients with carotid artery stenosis |
Page:631—634 |
| 164. Influence of intensive atorvastatin therapy on CIN and inflammatory response in patients with ischemic cerebrovascular disease after interventional surgery |
Page:623—627 |
| 165. Long noncoding RNA and atherosclerosis |
Page:679—682 |
| 166. Research progress of non-coding RNA effects in myocardial fibrosis |
Page:676—678 |
| 167. Role of lncRNA in cardiovascular disease |
Page:673—676 |
| 168. Research progress on application of exercise rehabilitation therapy in aged patients with hypertension |
Page:667—669 |
| 169. Biomarkers of pulmonary arterial hypertension of congenital heart disease and their significance |
Page:663—667 |
| 170. Relationship between abnormal ECG and cerebral vasospasm after aneurysmal subarachnoid hemor-rhage |
Page:660—662 |
| 171. Analysis of application effect of cardiac remote real -time monitoring system |
Page:656—660 |
| 172. Influence of tirofiban on plasma GDF-15 and serum PAF level in AMI patients undergoing PCI |
Page:651—655 |
| 173. Effects of amlodipine and atorvastatin calcium tablet on improving blood lipids and blood pressure in patients with hypertension complicated coronary heart disease |
Page:627—631 |
| 174. Therapeutic effect of noninvasive positive pressure ventilation on arrhythmia in patients with CHD complicated OSAHS |
Page:620—623 |
| 175. Influence of metoprolol combined lisinopril on cardiac function and serological markers in patients with heart failure |
Page:615—620 |
| 176. Therapeutic effect of edaravone combined butylphthalide on acute ischemic stroke and its safety |
Page:611—614 |
| 177. Influence of rehabilitation pathway treatment on therapeutic effect and prognosis of patients with non-ST elevation myocardial infarction undergoing PCI |
Page:607—610 |
| 178. Influence of hyperuricemia on ischemic stroke |
Page:602—606 |
| 179. Livin,IFN-γ and hemodynamic changes in patients with vascular dementia and their clinical signifi-cance |
Page:597—601 |
| 180. Influence of multi-stage psychological intervention on long-term prognosis of CHD patients undergoing revascularization |
Page:593—596 |
| 181. Influence of sertraline on quality of life in patients with chronic ischemic heart failure complicated de-pression |
Page:589—592 |
| 182. Application of health education in patients with coronary heart disease complicated diabetes mellitus |
Page:586—589 |
| 183. Influence of cardiac rehabilitation exercise guidance on quality of life in ACS patients after PCI |
Page:581—586 |